rayzebio.comHealthcareFounded: 2020Funding to Date: $238MM
RayzeBio develops novel peptide mimetic binders to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter.
For more details on financing and valuation for RayzeBio, register or login.
By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in
View Enterprise Value for RayzeBio.
To read this article and more news on RayzeBio, register or login.
By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in.
